Godfrey et al. failed to identify such mutations in human dystroglycanopathy patients (n = 33), suggesting that WWP1 might not be involved in human dystroglycanopathy [90]. This evidence concerns the gene WWP1 and neuromuscular disease caused by qualitative or quantitative defects of alpha-dystroglycan.